2015
TGA Approves AKYNZEO® (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Cerbios premiata allo Swiss Venture Club Prix 2015
![Cerbios-Pharma SA](http://www.farmaindustriaticino.ch/files/2016/07/logo-cerbios-FIT-Farma-Industria-300x300-1.png)
Terminato il secondo dei quattro moduli della seconda edizione del corso di formazione FIT
Certificate of Advanced Study in Pharmaceutical Organization and Processes
Intervista a Gabriel Haering di Cerbios Pharma
Helsinn Group Signs Exclusive Agreement with Mundipharma for Distribution and Licence of Anamorelin in China, Hong Kong and Macao
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Improved Bioavailability through cGMP super critical fluid atomization
Helsinn Group signs exclusive agreements with Mundipharma for distribution and licence of anamorelin in Brazil and across key markets in the Middle East and North Africa
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Helsinn Group signs exclusive agreement with Mundipharma for distribution and licensing of Netupitant/Palonosetron (nepa) in Brazil
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Linkedin